General Information of Drug (ID: DMEK1OJ)

Drug Name
JNJ-1459
Indication
Disease Entry ICD 11 Status REF
Psoriasis EA90 Phase 1 [1]
Cross-matching ID
TTD ID
DZ46KV

References

1 Clinical pipeline report, company report or official report of JOHNSON & JOHNSON